Why SNTI? Senti Biosciences, Inc. Analysis, Price & AI Insights | Whystock
SNTI
$1.02+0.10 (+10.28%)
Market ClosedLast close May 1
Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.